naphazoline has been researched along with Central Nervous System Diseases in 1 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Claudet, I | 1 |
| Fries, F | 1 |
1 other study available for naphazoline and Central Nervous System Diseases
| Article | Year |
|---|---|
[Danger of nasal vasoconstrictors in infants. Apropos of a case].
Topics: Cardiovascular Diseases; Central Nervous System Diseases; Dose-Response Relationship, Drug; Female; | 1997 |